Ledger.Open graph →
SEC Form D · filed April 2, 2021

KelSie Biotech Corp

Offering
$2.0M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
ENGLEWOOD, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Linda F. Sonntag · Englewood, CODirectorCameron F. Keluche · Englewood, COExec · DirectorJeffrey F. Howard · Englewood, CODirectorMichael F. Gruber · Englewood, CODirectorDaniel Ammann · San Francisco, CAExec · DirectorRegina Dugan · San Francisco, CADirectorMark Reuss · Detroit, MIDirectorWilliam Nash · San Francisco, CADirectorBen Kaanta · Englewood, COExec · DirectorAdrian Pertierra · Boca Raton, FLExec · DirectorDavid Sandberg · Boca Raton, FLDirectorKimberly Pollack · Hermosa Beach, CADirectorNorm E. Fjeldheim · Pleasanton, CADirectorBen Kaanta · Englewood, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗